Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Legend Biotech Corporation (LEGN)

  7. Legend Biotech Corporation (LEGN) News

LEGN

Legend Biotech Corporation

63.62
-0.55 (-0.86%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Legend Biotech Corporation LEGN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.55 -0.86% 63.62 20:00:00
Open Price Low Price High Price Close Price Prev Close
64.88 63.38 65.44 63.62 64.17
more quote information »

Recent News

Date Time Source Heading
6/01/20237:35IHNWFeaturedNew Break Announces Closing of $500,700 Non-Brokered Flow-Through Financing
6/01/202316:19EDGARReport of Proposed Sale of Securities (144)
5/27/202314:42BWLegend Biotech annonce une soumission à l’Agence européenne..
5/27/202311:56BWLegend Biotech beantragt erweiterte Anwendung von CARVYKTI®..
5/26/202309:02EDGARAutomatic Shelf Registration Statement of Securities of..
5/25/202308:30EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/25/202308:30BWLegend Biotech Announces Submission to the European..
5/18/202308:30BWLegend Biotech Reports First Quarter 2023 Results and Recent..
5/16/202308:40EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/16/202308:35BWLegend Biotech to Demonstrate Progress in Advancing..
5/12/202316:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/11/202316:01BWLegend Biotech Announces Participation in Upcoming Investor..
5/10/202309:46EDGARAmended Statement of Ownership (sc 13g/a)
5/08/202308:47EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/08/202308:30BWLegend Biotech Corporation Announces Pricing of Registered..
4/28/202316:14EDGARSmall Company Offering and Sale of Securities Without..
4/19/202314:44DJNLegend Biotech Up Over 18%, On Track for Record Percent..
4/19/202311:33EDGARReport of Proposed Sale of Securities (144)
4/19/202309:34EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/18/202308:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/11/202308:30BWLegend Biotech Announces Appointment of Chief Medical..
4/05/202317:01EDGARReport of Proposed Sale of Securities (144)
4/05/202316:59EDGARReport of Proposed Sale of Securities (144)
4/03/202316:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/03/202316:01BWLegend Biotech Establishes Strategic Advisory Board
4/03/202312:19EDGARReport of Proposed Sale of Securities (144)
3/30/202316:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/30/202316:01BWLegend Biotech Reports Full-Year 2022 Results and Recent..
2/24/202308:30BWLegend Biotech Announces Participation in Upcoming Investor..
2/21/202308:30BWLegend Biotech Regains Compliance with NASDAQ Listing Rule..
2/17/202307:25EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/17/202307:23EDGARAmended Report of Foreign Issuer Pursuant to Rule 13a-16 or..
2/14/202316:23EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202316:15EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202316:07EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202316:05EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202311:35EDGARStatement of Ownership (sc 13g)
1/27/202309:24DJNLegend Biotech Phase 3 Study of Carvykti Meets Primary..
1/27/202308:32BWLegend Biotech Announces Phase 3 CARTITUDE-4 Study of..
1/24/202316:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/09/202309:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/03/202316:01BWLegend Biotech to Participate in the 41st Annual JP Morgan..
1/02/202304:45BWLegend Biotech Announces Acceptance of Its New Drug..
12/12/202209:01TRMNAnalysts Offer Insights on Healthcare Companies: Amgen..
11/22/202216:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/22/202209:45TRMNLegend Biotech (LEGN) Gets a Buy from BMO Capital
11/21/202209:47DJNLegend Biotech Gets FDA Clearance for Small Cell Lung Cancer..
11/21/202208:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/21/202208:30BWLegend Biotech Announces FDA Clearance of IND Application..
11/06/202222:45TRMNBTIG Reaffirms Their Buy Rating on Legend Biotech (LEGN)
11/04/202217:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..